Parabilis Medicines

Peptide therapeutics (Helicon stapled-peptide platform, from Gregory Verdine's Harvard lab). Founded 2015 as Fog Pharmaceuticals; rebranded Parabilis Medicines. Undruggable intracellular targets; cancer. IPO closed 2026-06-11.